The burden and costs of prevention and management of genital disease caused by HPV in women: A population-based registry study in Finland

Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors

(2014) Jennifer S. Smith et al.   OBSTETRICS AND GYNECOLOGY

Age-Specific Effectiveness of the Finnish Cervical Cancer Screening Programme

(2012) S. Lonnberg et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease

(2012) Marc Arbyn et al.   INTERNATIONAL JOURNAL OF CANCER

Validation of histological diagnoses in a national cervical screening register

(2011) Stefan Lönnberg et al.   ACTA ONCOLOGICA

Worldwide burden of cervical cancer in 2008

(2011) M. Arbyn et al.   ANNALS OF ONCOLOGY

Early Natural History of Incident, Type-Specific Human Papillomavirus Infections in Newly Sexually Active Young Women

(2011) R. L. Winer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

(2011) Aimée R Kreimer et al.   LANCET ONCOLOGY

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Matti Lehtinen et al.   LANCET ONCOLOGY

HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

(2011) Joel M. Palefsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genital warts and cost of care in England

(2011) S. Desai et al.   SEXUALLY TRANSMITTED INFECTIONS

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

(2010) Ni Li et al.   INTERNATIONAL JOURNAL OF CANCER

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

(2010) Nubia Muñoz et al.   JNCI-Journal of the National Cancer Institute

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET